Search
Bausch Health Companies Inc
BHCAdd to Watchlist
5.710USD
-0.100-1.72%
Close 09-23 16:00（ET）
2.13BMarket Cap
LossP/E TTM
Bausch Health Companies Inc (BHC) Stock Price Target & Forecast
Analyst Rating
Based on 6 analysts giving stock ratings to Bausch Health Companies Inc in the past month.
Hold
0 Strong Buy
0 Buy
6 Hold
0 Sell
0 Strong Sell
Target Price
7.500USD+29.09%
BHC Analyst Recommendation Trends
In the current month, BHC has received 0 Buy Ratings, 6 Hold Ratings, and 0 Sell Ratings. BHC average Analyst price target in the last month is 7.500.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6
6
7
6
6
6
5
5
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
6
6
7
6
6
7
6
6
BHC Analyst Rating for Peer Comparison
Updated: Sep 23, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Biogen Inc
BIIB
7
17
12
1
0
37
Amgen Inc
AMGN
4
12
18
2
1
37
Eli Lilly and Co
LLY
10
17
6
1
0
34
AbbVie Inc
ABBV
8
19
6
0
0
33
Merck & Co Inc
MRK
8
14
10
0
0
32
Vertex Pharmaceuticals Inc
VRTX
9
16
5
0
1
31
Neurocrine Biosciences Inc
NBIX
13
14
4
0
0
31
Gilead Sciences Inc
GILD
7
18
6
0
0
31
Regeneron Pharmaceuticals Inc
REGN
6
14
10
0
0
30
Alnylam Pharmaceuticals Inc
ALNY
5
18
7
0
0
30
Financial Forecasting
Based on analysts' estimates, BHC EPS is projected to reach 1.235 in FY2026Q3, following reported EPS of 0.688 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
1.26
0.68
1.01
1.24
1.29
Actual
-0.30
-3.82
0.69
--
--
Surprise
-123.92%
-665.49%
-31.68%
--
--
FAQs
What is Bausch Health Companies Inc's expected revenue for the next quarter?
Bausch Health Companies Inc's expected revenue is 2.74B.
What is Bausch Health Companies Inc's price target?
Analysts forecast that Bausch Health Companies Inc's price target is USD 7.50, with the highest forecast at USD 9.00 and the lowest forecast at USD 6.50.
How have Bausch Health Companies IncBHC's recent earnings per share performed?
The market expectation was USD 0.69, while Bausch Health Companies IncBHC's earnings per share (EPS) for the previous quarter was USD -3.82. EPS for the next quarter is expected at USD 1.24.
What is the analyst rating for Bausch Health Companies Inc?
Based on the ratings of Bausch Health Companies Inc's stock from 6 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.